Background: Postpartum contraception reduces the risk of unintended and rapid repeat pregnancies. A comprehensive postpartum family planning (PPFP) service can enable women make adequate and informed choices on a preferred contraceptive method, initiating a method as well as encouraging them to use that method for a period depending on their reproductive intentions.Methods: This study aimed to determine women’s intention regarding uptake of postpartum family planning, the preferred methods and the factors associated with uptake. We conducted a cross-sectional study among women attending antenatal and postnatal clinics at the Jos University Teaching Hospital, Jos, Nigeria using structured questionnaires. Data was analyzed using descriptive statistics and chi square test of comparison.Results: Four hundred and five women participated in the study. The mean age of the respondents was 28.4+5.3 years. The previous contraceptive usage was 39.8%. A total of 262 (64%) women intend to use a method of postpartum contraception. The most preferred intended postpartum contraceptive was subdermal implant (19.2%) followed by injectables (18.4%) and intrauterine contraceptive device (14.7%). Reasons cited for nonuse of postpartum contraception include spousal refusal, effect on fertility, desire for further child bearing, religious beliefs.Conclusions: Counselling on postpartum contraception during the antenatal and postnatal period can help women make informed choices among the wide range of available contraception.

No abstract

No abstract

| Globally, over 20 million of hepatitis D virus (HDV) are coinfected with Hepatitis B virus, which has an estimate of 350 million infected individuals. The study aimed to determine the prevalence of HDV infection in HBV/HIV and HBV-mono infected patients in Jos, Nigeria. This cross-sectional study was conducted on ninety (45 HBV/HBV and 45 HBV-mono) infected patients with chronic hepatitis B attending the hepatitis clinics of the two tertiary hospitals (Plateau State Teaching Hospital and HIV treatment center, at Jos University Teaching Hospital), Jos Metropolis from September to December 2018. The anti-HDV antibodies (IgM) were assayed using enzyme-linked immunosorbent assay HDV IgM ELISA Kit (MyBiosource, Inc, USA). The result was interpreted according to manufacturer's instructions. Ninety HBsAg positive patient were included (45 HBV/HIV, and 45 HBV-mono infected patients), 36 (40.0%) males, and 54 (60.0%) were females, with the overall mean age of 38.7 ±13years. However, the mean age was higher (36±13.1 years) in the HBV/HIV as compared to HBV-mono (40.6 ±12.7 years) infected patients. The mean age of patients was 36,92 ± 15,35 years. One hundred and three (63.6%) of them were males and 59 (36,4%) were females. Ten (11.1%) of patients were positive for anti-HD antibodies. the infection among the HBV/HBV was 13.3% and HBV-mono 8.9%. In the statistical analysis, the HBV-mono infected; age (p=.037), marital status (p=.001), cigarette smoking (p=.022) and condom use (p=.04) were significantly related to HDV infection. The study demonstrated high prevalence of HDV infection, which is imperative for policy makers and health care providers to strengthen the prevention measures for HDV, including the use of HBV prevention vaccine. Also, it is important to screen chronic HBV patients for HDV for early detection to avert subsequent development of end stage liver disease. Furthermore, larger studies are needed to gain better understanding of the HDV infection among chronic hepatitis B patients in endemic regions and other high-risk populations.